WHO ICTRP trial
Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux…
JPRN-jRCT1080223147 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT1080223147 |
|---|---|
| Public title | Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux Esophagitis: Long-term Use" |
| Scientific title | Special Drug Use Surveillance of Takecab Tablets for "Maintenance Therapy of Reflux Esophagitis: Long-term Use" |
| Primary sponsor | Takeda Pharmaceutical Company Limited |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Countries | Japan |
| Conditions | Reflux Esophagitis |
| Interventions | investigational material(s) Generic name etc : Vonoprazan 10 mg or 20 mg INN of investigational material : Vonoprazan Therapeutic category code : 232 Agents for peptic ulcer Dosage and Administration for Investigational material : Usually… |
| Registration date | Mar 16, 2016 |
| Target size | 1237 |
| Secondary IDs | NCT03214081;JapicCTI-163202 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: